Tsuzuki Yasunori, Tomita Kyoji, Shibamori Koh-ichiro, Sato Yuji, Kashimoto Shigeki, Chiba Katsumi
Chemistry Research Laboratories, Dainippon Pharmaceutical Co. Ltd., Enoki 33-94, Suita, Osaka 564-0053, Japan.
J Med Chem. 2004 Apr 8;47(8):2097-109. doi: 10.1021/jm0304966.
We have previously reported that a series of 7-substituted 6-fluoro-1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids possess moderate cytotoxic activity. In a further attempt to find clinically useful antitumor agents, we investigated the structure-activity relationships (SARs) of a new series of compounds obtained by changing the C-6 position of the fluorine atom in addition to the C-5 and C-7 positions and evaluating their cytotoxic activity against several murine and human tumor cell lines. Our results showed that the 6-unsubstituted 1,8-naphthyridine structure had the most potent cytotoxic activity against murine P388 leukemia twice that of the 6-fluoro analogue. In addition, introduction of an amino group at the C-5 position did not have any substantial effect on the cytotoxic activity, while both the 5-chloro and 5-trifluoromethyl groups decreased the cytotoxic activity by 5- to 10-fold. Moreover, aminopyrrolidine derivatives at the C-7 position showed more potent cytotoxic activity than other amines or carbon derivatives. Among the 7-(3-aminopyrrolidinyl) derivatives, the trans-3-methoxy-4-methylaminopyrrolidinyl derivative (27l) was determined to have potent cytotoxic activity in both in vitro and in vivo assays and high water solubility. Finally, the (S,S)-isomer (AG-7352, 3) of 27l, with a cytotoxic activity against human tumor cell lines more potent than that of etoposide, was selected for further development.
我们之前报道过,一系列7-取代的6-氟-1,4-二氢-4-氧代-1-(2-噻唑基)-1,8-萘啶-3-羧酸具有中等细胞毒性活性。为了进一步寻找临床上有用的抗肿瘤药物,我们研究了一系列新化合物的构效关系(SARs),这些化合物是通过改变除C-5和C-7位以外的C-6位氟原子,并评估它们对几种小鼠和人类肿瘤细胞系的细胞毒性活性而获得的。我们的结果表明,6-未取代的1,8-萘啶结构对小鼠P388白血病具有最强的细胞毒性活性,是6-氟类似物的两倍。此外,在C-5位引入氨基对细胞毒性活性没有任何实质性影响,而5-氯和5-三氟甲基基团均使细胞毒性活性降低了5至10倍。此外,C-7位的氨基吡咯烷衍生物显示出比其他胺类或碳衍生物更强的细胞毒性活性。在7-(3-氨基吡咯烷基)衍生物中,反式-3-甲氧基-4-甲基氨基吡咯烷基衍生物(27l)在体外和体内试验中均具有较强的细胞毒性活性且水溶性高。最后,选择27l的(S,S)-异构体(AG-7352,3)进行进一步开发,其对人类肿瘤细胞系的细胞毒性活性比依托泊苷更强。